{
  "id": 12137855,
  "title": "Satellos Granted Composition of Matter Patent for Forazapadin",
  "url": "https://urgent.news/2026/10/05/satellos-granted-composition-of-matter-patent-for-forazapadin",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-05T11:03:12.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/satellos-granted-composition-of-matter-patent-for-forazapadin"
  },
  "original_language": "en",
  "account": null,
  "summary": "Composition of matter provides U.S. protection through Sept. 6, 2044, as forazapadin advances in Phase 2 development TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing potentially life-improving medicines to treat degenerative muscle diseases, today announced that the United States Patent and Trademark…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}